IQVIA Holdings Inc (IQV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, IQVIA Holdings Inc (IQV) has a cash flow conversion efficiency ratio of 0.089x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($558.00 Million) by net assets ($6.30 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see IQV stock market capitalisation for the company's overall valuation and market capitalisation.
IQVIA Holdings Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how IQVIA Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
IQVIA Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of IQVIA Holdings Inc ranked by their cash flow conversion efficiency. Explore IQV cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GigaDevice Semiconductor(Beiji
SHG:603986
|
0.035x |
|
Commerzbank AG
XETRA:CBK
|
-0.209x |
|
CITIC LTD. ADR/5 HD-40
F:CPF0
|
N/A |
|
UCB SA
BR:UCB
|
0.032x |
|
Garmin Ltd
F:GEY
|
0.058x |
|
Prudential plc
MX:PUKN
|
0.030x |
|
Nokia Corp ADR
NYSE:NOK
|
0.018x |
|
American International Group Inc
NYSE:AIG
|
0.004x |
Annual Cash Flow Conversion Efficiency for IQVIA Holdings Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of IQVIA Holdings Inc from 2011 to 2025. View IQVIA Holdings Inc stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $6.63 Billion | $2.65 Billion | 0.400x | -10.58% |
| 2024-12-31 | $6.07 Billion | $2.72 Billion | 0.448x | +27.32% |
| 2023-12-31 | $6.11 Billion | $2.15 Billion | 0.352x | -10.31% |
| 2022-12-31 | $5.76 Billion | $2.26 Billion | 0.392x | -19.49% |
| 2021-12-31 | $6.04 Billion | $2.94 Billion | 0.487x | +56.09% |
| 2020-12-31 | $6.28 Billion | $1.96 Billion | 0.312x | +37.88% |
| 2019-12-31 | $6.26 Billion | $1.42 Billion | 0.226x | +25.47% |
| 2018-12-31 | $6.95 Billion | $1.25 Billion | 0.180x | +55.38% |
| 2017-12-31 | $8.36 Billion | $970.00 Million | 0.116x | +19.57% |
| 2016-12-31 | $8.86 Billion | $860.00 Million | 0.097x | +106.85% |
| 2015-12-31 | $-335.68 Million | $475.69 Million | -1.417x | -131.07% |
| 2014-12-31 | $-704.01 Million | $431.75 Million | -0.613x | -3.02% |
| 2013-12-31 | $-667.49 Million | $397.37 Million | -0.595x | -141.01% |
| 2012-12-31 | $-1.36 Billion | $335.70 Million | -0.247x | -48.80% |
| 2011-12-31 | $-969.60 Million | $160.95 Million | -0.166x | -- |
About IQVIA Holdings Inc
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more